• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生态学新视角:揭开运动调节心血管代谢疾病的面纱。

A new perspective in intestinal microecology: lifting the veil of exercise regulation of cardiometabolic diseases.

机构信息

College of Exercise and Health, Shenyang Sport University, Shenyang, Liaoning, P. R. China.

Department of Cardiology, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, P. R. China.

出版信息

Gut Microbes. 2024 Jan-Dec;16(1):2404141. doi: 10.1080/19490976.2024.2404141. Epub 2024 Sep 21.

DOI:10.1080/19490976.2024.2404141
PMID:39305272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11418258/
Abstract

Cardiometabolic diseases (CMDs), encompassing cardiovascular and metabolic dysfunctions, characterized by insulin resistance, dyslipidemia, hepatic steatosis, and inflammation, have been identified with boosting morbidity and mortality due to the dearth of efficacious therapeutic interventions. In recent years, studies have shown that variations in gut microbiota and its own metabolites can influence the occurrence of CMDs. Intriguingly, the composition and function of the gut microbiota are susceptible to exercise patterns, thus affecting inflammatory, immune, and metabolic responses within the host. In this review, we introduce the key mechanisms of intestinal microecology involved in the onset and development of CMDs, discuss the relationship between exercise and intestinal microecology, and then analyze the role of intestinal microecology in the beneficial effects of exercise on CMDs, aiming at elucidating the gut-heart axis mechanisms of exercise mediated protective effect on CMDs, building avenues for the application of exercise in the management of CMDs.

摘要

心血管代谢疾病(CMD)涵盖了心血管和代谢功能障碍,其特征是胰岛素抵抗、血脂异常、肝脂肪变性和炎症,由于缺乏有效的治疗干预措施,发病率和死亡率不断上升。近年来的研究表明,肠道微生物群及其自身代谢物的变化会影响 CMD 的发生。有趣的是,肠道微生物群的组成和功能易受运动模式的影响,从而影响宿主的炎症、免疫和代谢反应。在这篇综述中,我们介绍了肠道微生态在 CMD 发生和发展中涉及的关键机制,讨论了运动与肠道微生态的关系,然后分析了肠道微生态在运动对 CMD 有益作用中的作用,旨在阐明运动对 CMD 的保护作用的肠道-心脏轴机制,为运动在 CMD 管理中的应用开辟途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d7/11418258/d3a84e5c097a/KGMI_A_2404141_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d7/11418258/942d4351a4eb/KGMI_A_2404141_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d7/11418258/eac10fbf8433/KGMI_A_2404141_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d7/11418258/f17834401a70/KGMI_A_2404141_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d7/11418258/c27f04f41114/KGMI_A_2404141_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d7/11418258/41d2176d33e9/KGMI_A_2404141_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d7/11418258/d3a84e5c097a/KGMI_A_2404141_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d7/11418258/942d4351a4eb/KGMI_A_2404141_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d7/11418258/eac10fbf8433/KGMI_A_2404141_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d7/11418258/f17834401a70/KGMI_A_2404141_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d7/11418258/c27f04f41114/KGMI_A_2404141_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d7/11418258/41d2176d33e9/KGMI_A_2404141_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d7/11418258/d3a84e5c097a/KGMI_A_2404141_F0006_OC.jpg

相似文献

1
A new perspective in intestinal microecology: lifting the veil of exercise regulation of cardiometabolic diseases.肠道微生态学新视角:揭开运动调节心血管代谢疾病的面纱。
Gut Microbes. 2024 Jan-Dec;16(1):2404141. doi: 10.1080/19490976.2024.2404141. Epub 2024 Sep 21.
2
Role of the gut microbiota in type 2 diabetes and related diseases.肠道微生物群在 2 型糖尿病及相关疾病中的作用。
Metabolism. 2021 Apr;117:154712. doi: 10.1016/j.metabol.2021.154712. Epub 2021 Jan 23.
3
[Gut microbiota and immune crosstalk in metabolic disease].[代谢性疾病中的肠道微生物群与免疫相互作用]
Biol Aujourdhui. 2017;211(1):1-18. doi: 10.1051/jbio/2017008. Epub 2017 Jul 6.
4
The gut microbiome, diet, and links to cardiometabolic and chronic disorders.肠道微生物组、饮食与心血管代谢和慢性疾病的关联。
Nat Rev Nephrol. 2016 Mar;12(3):169-81. doi: 10.1038/nrneph.2015.191. Epub 2015 Nov 30.
5
Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health.肠道微生物群衍生的短链脂肪酸在代谢和心血管健康中的作用。
Curr Nutr Rep. 2018 Dec;7(4):198-206. doi: 10.1007/s13668-018-0248-8.
6
Role of Gut Microecology in the Pathogenesis of Drug-Induced Liver Injury and Emerging Therapeutic Strategies.肠道微生态在药物性肝损伤发病机制中的作用及新兴治疗策略。
Molecules. 2024 Jun 4;29(11):2663. doi: 10.3390/molecules29112663.
7
The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease.微生物组与宿主中枢神经系统的相互作用:肠道-大脑轴作为治疗肥胖和心血管代谢疾病的潜在新治疗靶点。
Expert Opin Ther Targets. 2020 Jul;24(7):639-653. doi: 10.1080/14728222.2020.1761958. Epub 2020 May 22.
8
Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota.通过肠道微生物群改善代谢疾病的中药治疗机制。
Biomed Pharmacother. 2021 Jan;133:110857. doi: 10.1016/j.biopha.2020.110857. Epub 2020 Nov 13.
9
The Metabolic Role and Therapeutic Potential of the Microbiome.微生物组的代谢作用及治疗潜力
Endocr Rev. 2022 Sep 26;43(5):907-926. doi: 10.1210/endrev/bnac004.
10
An update on the effects of food-derived active peptides on the intestinal microecology.食品源活性肽对肠道微生态影响的研究进展。
Crit Rev Food Sci Nutr. 2023 Nov;63(33):11625-11639. doi: 10.1080/10408398.2022.2094889. Epub 2022 Jul 6.

引用本文的文献

1
Gut microbiota and osteoarthritis: epidemiology, mechanistic analysis, and new horizons for pharmacological interventions.肠道微生物群与骨关节炎:流行病学、机制分析及药物干预新视野
Front Cell Infect Microbiol. 2025 Jul 16;15:1605860. doi: 10.3389/fcimb.2025.1605860. eCollection 2025.
2
Mechanisms of exercise in preventing cardiovascular diseases: Insights from gut microbiota characteristics in pathological states of cardiovascular diseases.运动预防心血管疾病的机制:从心血管疾病病理状态下的肠道微生物群特征中获得的见解
Rev Endocr Metab Disord. 2025 Jun 9. doi: 10.1007/s11154-025-09971-8.

本文引用的文献

1
Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial.姜黄素补充剂可减轻非酒精性单纯性脂肪性肝病患者的肝脂肪含量,其作用机制与调节肠道微生物群依赖性胆汁酸代谢有关:一项随机对照试验。
Am J Clin Nutr. 2024 Jul;120(1):66-79. doi: 10.1016/j.ajcnut.2024.05.017. Epub 2024 May 23.
2
Effects of Functional Strength Training Combined with Aerobic Training on Body Composition, Physical Fitness, and Movement Quality in Obese Adolescents.功能性力量训练联合有氧训练对肥胖青少年身体成分、体适能和动作质量的影响。
Nutrients. 2024 May 9;16(10):1434. doi: 10.3390/nu16101434.
3
Unraveling the Microbiome-Human Body Axis: A Comprehensive Examination of Therapeutic Strategies, Interactions and Implications.
解析微生物组-人体轴心:治疗策略、相互作用和影响的综合考察。
Int J Mol Sci. 2024 May 20;25(10):5561. doi: 10.3390/ijms25105561.
4
Unveiling the microbiota-metabolite-myocardium axis: a novel perspective on cardiovascular health.揭示微生物群-代谢物-心肌轴:心血管健康的新视角。
Front Microbiol. 2024 May 9;15:1389311. doi: 10.3389/fmicb.2024.1389311. eCollection 2024.
5
Targeting Non-Alcoholic Fatty Liver Disease with Hawthorn Ethanol Extract (HEE): A Comprehensive Examination of Hepatic Lipid Reduction and Gut Microbiota Modulation.以山楂乙醇提取物(HEE)靶向治疗非酒精性脂肪性肝病:肝脂减少和肠道微生物群调节的综合研究。
Nutrients. 2024 Apr 29;16(9):1335. doi: 10.3390/nu16091335.
6
Petroleum ether extract of Schisandra sphenanthera prevents hyperglycemia and insulin resistance in association with modulation of sweet taste receptors and gut microbiota in T2DM rats.北五味子石油醚提取物通过调节 T2DM 大鼠甜味受体和肠道微生物群来预防高血糖和胰岛素抵抗。
J Ethnopharmacol. 2024 Sep 15;331:118300. doi: 10.1016/j.jep.2024.118300. Epub 2024 May 7.
7
Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease.肝选择性胰岛素抵抗:胰岛素信号与代谢功能障碍相关脂肪性肝病的交汇点。
Cell Metab. 2024 May 7;36(5):947-968. doi: 10.1016/j.cmet.2024.04.006.
8
Beyond Obesity and Overweight: The Clinical Assessment and Treatment of Excess Body Fat in Children : Part 1 - Insulin Resistance as the Root Cause of Pediatric Obesity.超越肥胖和超重:儿童体脂肪过多的临床评估和治疗:第 1 部分 - 胰岛素抵抗是儿童肥胖的根本原因。
Curr Obes Rep. 2024 Jun;13(2):276-285. doi: 10.1007/s13679-024-00565-0. Epub 2024 May 6.
9
Network and Experimental Pharmacology on Mechanism of Yixintai Regulates the TMAO/PKC/NF-κB Signaling Pathway in Treating Heart Failure.益肾泰调节 TMAO/PKC/NF-κB 信号通路治疗心力衰竭的网络与实验药理学研究。
Drug Des Devel Ther. 2024 Apr 30;18:1415-1438. doi: 10.2147/DDDT.S448140. eCollection 2024.
10
Platelets as an inter-player between hyperlipidaemia and atherosclerosis.血小板在高脂血症和动脉粥样硬化之间的作用。
J Intern Med. 2024 Jul;296(1):39-52. doi: 10.1111/joim.13794. Epub 2024 May 5.